MyBlueDotsAspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics MyBlueDots6 months ago01 mins VANCOUVER, British Columbia–(BUSINESS WIRE)– #biotech–Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional cures for serious diseases Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
Why we need to take concussion and chronic traumatic encephalopathy more seriously MyBlueDots4 days ago 0
Foreign medical residents fill critical positions at US hospitals, but are running into visa issues MyBlueDots5 days ago 0